Easom Eric 4
4 · AN2 Therapeutics, Inc. · Filed Nov 9, 2022
Insider Transaction Report
Form 4
Easom Eric
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2022-11-09$15.61/sh−10,111$157,847→ 4,907 total - Sale
Common Stock
2022-11-08$16.38/sh−1,255$20,559→ 15,018 total - Sale
Common Stock
2022-11-08$15.41/sh−5,800$89,388→ 16,273 total
Footnotes (1)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.